According to NanoViricides's latest financial reports the company's current earnings (TTM) are -$9.36 M. In 2022 the company made an earning of -$6.89 M an increase over its 2021 earnings that were of -$8.72 M.The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Year | Earnings | Change |
---|---|---|
2023 (TTM) | -$9.36 M | 35.83% |
2022 | -$6.89 M | -20.96% |
2021 | -$8.72 M | -40.3% |
2020 | -$14.6 M | 86.2% |
2019 | -$7.85 M | 0.09% |
2018 | -$7.84 M | -25.39% |
2017 | -$10.5 M | -6.68% |
2016 | -$11.26 M | 114.25% |
2015 | -$5.26 M | -5.43% |
2014 | -$5.56 M | -59.73% |
2013 | -$13.79 M | 106.16% |
2012 | -$6.69 M | 5.57% |
2011 | -$6.34 M | 6.42% |
2010 | -$5.96 M | 93.61% |
2009 | -$3.08 M | -4.07% |
2008 | -$3.21 M | 19.12% |
2007 | -$2.7 M |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
Gilead Sciences GILD | $6.85 B | -73,407.48% | ๐บ๐ธ USA |
Merck MRK | $3.03 B | -32,537.41% | ๐บ๐ธ USA |
Bristol-Myers Squibb BMY | $8.44 B | -90,304.86% | ๐บ๐ธ USA |
GlaxoSmithKline GSK | $7.53 B | -80,632.64% | ๐ฌ๐ง UK |
Novavax NVAX | -$0.53 B | 5,549.72% | ๐บ๐ธ USA |
BioCryst Pharmaceuticals
BCRX | -$0.23 B | 2,317.89% | ๐บ๐ธ USA |